Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2016, Article ID 3852126, 8 pages
Review Article

Elbasvir/Grazoprevir: A Review of the Latest Agent in the Fight against Hepatitis C

1Department of Pharmacy Practice, University of Mississippi School of Pharmacy, Jackson, MS 39216, USA
2Department of Medicine-Infectious Diseases, University of Mississippi Medical Center, Jackson, MS 39216, USA

Received 30 March 2016; Accepted 24 May 2016

Academic Editor: Maria Buti

Copyright © 2016 Allison M. Bell et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [13 citations]

The following is the list of published articles that have cited the current article.

  • Takashi E. Komatsu, Sarita Boyd, Adam Sherwat, LaRee Tracy, Lisa K. Naeger, Julian J. O’Rear, and Patrick R. Harrington, “Regulatory Analysis of Effects of Hepatitis C Virus NS5A Polymorphisms on Efficacy of Elbasvir and Grazoprevir,” Gastroenterology, 2016. View at Publisher · View at Google Scholar
  • Min Gu Kang, Min Jung Kang, Eunhee Ji, and Bong Kyu Yoo, “Meta-analysis of the Efficacy and Safety of Grazoprevir and Elbasvir for the Treatment of Hepatitis C Virus Infection,” Korean Journal of Clinical Pharmacy, vol. 27, no. 3, pp. 150–160, 2017. View at Publisher · View at Google Scholar
  • C. Nelson Hayes, and Kazuaki Chayama, “Why highly effective drugs are not enough: the need for an affordable solution to eliminating HCV,” Expert Review of Clinical Pharmacology, pp. 1–12, 2017. View at Publisher · View at Google Scholar
  • Alyssa M. Austria, Vjera Ninčević, and George Y. Wu, “A Brief Update on the Treatment of Hepatitis C,” Update on Hepatitis C, 2017. View at Publisher · View at Google Scholar
  • Serkan Öncü, Deniz Özkaya, Kaya Süer, Süda Tekin, Nazan Tuna, Neşe Demirtürk, Nesrin Türker, Ali Asan, Derya Keten, Safiye Koçulu, Bilgehan Aygen, Neşe Saltoğlu, Murat Sayan, Alper Şener, Saadet Yazıcı, Haluk Eraksoy, Yunus Gürbüz, and Dilara İnan, “Management of chronic hepatitis C virus infection: A consensus report of the study group for viral hepatitis of the Turkish society of clinical microbiology and infectious diseases-2017 update,” Klimik Dergisi, vol. 30, no. 1, pp. 2–35, 2017. View at Publisher · View at Google Scholar
  • Mariola Dutkiewicz, and Jerzy Ciesiołka, “Form confers function: Case of the 3’X region of the hepatitis C virus genome,” World Journal of Gastroenterology, vol. 24, no. 30, pp. 3374–3383, 2018. View at Publisher · View at Google Scholar
  • Tomoko Tadokoro, Tsutomu Masaki, Kyoko Oura, Teppei Sakamoto, Hirohito Yoneyama, Asahiro Morishita, Koji Fujita, Shima Mimura, Takako Nomura, and Joji Tani, “Grazoprevir/elbasvir treatment for the relapse of hcv genotype 1b infection after ledipasvir/sofosbuvir: A case report,” Experimental and Therapeutic Medicine, vol. 16, no. 2, pp. 1026–1028, 2018. View at Publisher · View at Google Scholar
  • Sern Wei Yeoh, Alex C. N. Holmes, Michael M. Saling, Ian P. Everall, and Amanda J. Nicoll, “Depression, fatigue and neurocognitive deficits in chronic hepatitis C,” Hepatology International, 2018. View at Publisher · View at Google Scholar
  • Yuvaram N. V. Reddy, David Nunes, Vipul Chitalia, Craig E. Gordon, and Jean M. Francis, “Hepatitis C virus infection in kidney transplantation-changing paradigms with novel agents,” Hemodialysis International, vol. 22, pp. S53–S60, 2018. View at Publisher · View at Google Scholar
  • Madhavi, and Prameelarani, “Simultaneous reverse-phase ultra performance liquid chromatography method development and validation for estimation of grazoprevir and elbasvir,” Asian Journal of Pharmaceutical and Clinical Research, vol. 11, no. 4, pp. 100–104, 2018. View at Publisher · View at Google Scholar
  • Sumita Verma, Ahmed Hashim, Margaret O'Sullivan, and Hugh Williams, “Developing a community HCV service: Project ITTREAT (integrated community-based test-stage-TREAT) service for people who inject drugs,” Primary Health Care Research and Development, vol. 19, no. 2, pp. 110–120, 2018. View at Publisher · View at Google Scholar
  • Binay Chaubey, and Anirban Mandal, “Expression of Duplex shRNAs through a Lentiviral Vector against Cellular and Viral Genes Inflicts Sustained Inhibition of Hepatitis C Virus Replication,” Intervirology, vol. 61, no. 2, pp. 79–91, 2018. View at Publisher · View at Google Scholar
  • Youngsu You, Hee Sun Kim, Jung Woo Park, Gyochang Keum, Sung Key Jang, and B. Moon Kim, “ Sulfur( vi ) fluoride exchange as a key reaction for synthesizing biaryl sulfate core derivatives as potent hepatitis C virus NS5A inhibitors and their structure–activity relationship studies ,” RSC Advances, vol. 8, no. 55, pp. 31803–31821, 2018. View at Publisher · View at Google Scholar